Oppenheimer & Co’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,163
| Closed | -$397K | – | 1609 |
|
|
2021
Q2 | $397K | Buy |
2,163
+57
| +3% | +$9.78K | 0.01% | 1123 |
|
|
2021
Q1 | $322K | Sell |
2,106
-42
| -2% | -$6.5K | 0.01% | 1142 |
|
|
2020
Q4 | $336K | Buy |
2,148
+100
| +5% | +$12.8K | 0.01% | 1048 |
|
|
2020
Q3 | $234K | Sell |
2,048
-12
| -0.6% | -$1.29K | 0.01% | 1097 |
|
|
2020
Q2 | $231K | Sell |
2,060
-1,691
| -45% | -$180K | 0.01% | 1061 |
|
|
2020
Q1 | $337K | Sell |
3,751
-4,415
| -54% | -$433K | 0.01% | 866 |
|
|
2019
Q4 | $883K | Sell |
8,166
-6,976
| -46% | -$746K | 0.02% | 664 |
|
|
2019
Q3 | $1.48M | Sell |
15,142
-929
| -6% | -$105K | 0.04% | 481 |
|
|
2019
Q2 | $2.1M | Sell |
16,071
-287
| -2% | -$37K | 0.06% | 385 |
|
|
2019
Q1 | $2.21M | Buy |
16,358
+1,258
| +8% | +$156K | 0.06% | 361 |
|
|
2018
Q4 | $1.47M | Buy |
15,100
+6,896
| +84% | +$815K | 0.05% | 410 |
|
|
2018
Q3 | $1.14M | Buy |
8,204
+537
| +7% | +$67.4K | 0.03% | 562 |
|
|
2018
Q2 | $952K | Sell |
7,667
-345
| -4% | -$40.3K | 0.03% | 614 |
|
|
2018
Q1 | $893K | Buy |
8,012
+2,158
| +37% | +$258K | 0.02% | 649 |
|
|
2017
Q4 | $700K | Buy |
5,854
+1,293
| +28% | +$157K | 0.02% | 738 |
|
|
2017
Q3 | $640K | Buy |
4,561
+383
| +9% | +$52K | 0.02% | 762 |
|
|
2017
Q2 | $508K | Buy |
+4,178
| New | +$486K | 0.01% | 826 |
|
|
2016
Q2 | – | Sell |
-2,480
| Closed | -$345K | – | 1316 |
|
|
2016
Q1 | $345K | Sell |
2,480
-797
| -24% | -$117K | 0.01% | 886 |
|
|
2015
Q4 | $625K | Sell |
3,277
-569
| -15% | -$99.4K | 0.02% | 698 |
|
|
2015
Q3 | $601K | Buy |
3,846
+10
| +0.3% | +$1.82K | 0.02% | 743 |
|
|
2015
Q2 | $693K | Sell |
3,836
-819
| -18% | -$141K | 0.02% | 743 |
|
|
2015
Q1 | $807K | Sell |
4,655
-553
| -11% | -$100K | 0.02% | 703 |
|
|
2014
Q4 | $964K | Sell |
5,208
-1,943
| -27% | -$360K | 0.03% | 617 |
|
|
2014
Q3 | $1.19M | Sell |
7,151
-1,666
| -19% | -$274K | 0.04% | 550 |
|
|
2014
Q2 | $1.38M | Sell |
8,817
-1,626
| -16% | -$257K | 0.04% | 497 |
|
|
2014
Q1 | $1.59M | Buy |
10,443
+535
| +5% | +$85.1K | 0.05% | 445 |
|
|
2013
Q4 | $1.32M | Buy |
9,908
+3,577
| +56% | +$429K | 0.04% | 476 |
|
|
2013
Q3 | $736K | Buy |
6,331
+3,048
| +93% | +$334K | 0.03% | 632 |
|
|
2013
Q2 | $303K | Buy |
+3,283
| New | +$316K | 0.01% | 925 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM